Lactose (India) — 360° view

Lactose (India), a company in the Pharmaceuticals industry, reported revenue of ₹47 crore and net profit of ₹2.37 crore for the June 2026 quarter.

Lactose (India) (BSE: LACTOSE) closed at ₹88.90 on 20 Nov 2026, down 29.8% over the past year. Its market capitalisation is ₹112 crore and it trades at 16.1 times earnings.

Share price
₹88.90 (20 Nov 2026)
Market cap
₹112 Cr (20 Nov 2026)
P/E
16.13 (20 Nov 2026)
Revenue
₹47 Cr (June 2026 quarter)
Net profit
₹2 Cr (June 2026 quarter)
ROCE
11.3% (FY26)
ROE
9.81% (FY26)
Book value
₹51.5 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹136.45 / ₹76.01 (20 Nov 2026)
1-year return
-29.8% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: LACTOSE

Incorporated in 1991, Lactose (India) Ltd manufactures Pharmaceutical Products and carries out job work

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.